AN UPDATE ON HYPERURICEMIA - WHEN TO TREAT AND WHEN NOT TO TREAT

Vasantha Kamath, Dharani S.*

ABSTRACT

The rising prevalence of asymptomatic hyperuricemia presents a clinical challenge regarding the decision to treat. While guidelines advocate for the initiation of urate-lowering therapy (ULT) in symptomatic hyperuricemia, there is a notable gap in recommendations for managing asymptomatic cases. Given uric acid's involvement in various physiological systems and its role in disease pathogenesis, it is essential to conduct comprehensive studies to develop individualized treatment strategies that optimize health outcomes.

Keywords: Uric acid, Hyperuricemia, Asymptomatic, Gout, Urate-lowering therapy.